Estrogen receptor α inhibits IL-1β induction of gene expression in the mouse liver

Endocrinology

Volumn 143, Issue 7, 2002, Pages 2559-2570

  Evans, Mark J ^a   Lai, Kehdih ^a   Shaw, Lucinda J ^a   Harnish, Douglas C ^a   Chadwick, Christopher C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ESTROGEN RECEPTOR ALPHA; INTERLEUKIN 1BETA; PROSTAGLANDIN D SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; LIVER PARENCHYMA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RECEPTOR AFFINITY; RECEPTOR BINDING; SEPSIS; TRANSCRIPTION REGULATION;

EID: 0036280813     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.7.8919     Document Type: Article

References (59)

1. Septic shock
2. Cytokines and the hepatic acute-phase response
3. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
4. Gender differences in human sepsis
5. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males
6. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis
7. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
8. 17 β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
9. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
10. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor
11. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor
12. The oestrogen receptor regulates NFκB and AP-1 activity in a cell-specific manner
13. Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
14. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site
15. Estrogen inhibits phorbol ester-induced IκBα transcription and protein degradation
16. The role of CBP in estrogen receptor cross-talk with nuclear factor-κB in HepG2 cells
17. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-κB in human coronary smooth muscle cells
18. Cloning of a novel receptor expressed in rat prostate and ovary
19. Estrogen receptors α and β form heterodimers on DNA
20. Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor alpha
21. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
22. Estrogen receptor β: Re-evaluation of estrogen and antiestrogen signaling
23. Functional analysis of a novel estrogen receptor-β isoform
24. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: Correlations with biological character and distinct differences among SRC coactivator family members
25. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
26. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
27. Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues
28. Estrogen receptor levels and occupancy in hepatic sinusoidal endothelial and Kupffer cells are enhanced by initiation with diethylnitrosamine and promotion with 17α-ethinylestradiol in rats
29. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo
30. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury
31. Reciprical antagonism between estrogen receptor and NF-κB activity in vivo
32. Comparison between effects of interleukin-1 α administration and sublethal endotoxemia in primates
33. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
34. Estradiol-regulated transamidation of keratins by vaginal epithelial cell transglutaminase
35. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-κB
36. Antioxidant properties of steroids
37. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
38. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
39. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
40. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen
41. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells
42. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene
43. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth
44. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
45. Cytokine-mediated differential regulation of macrophage activator protein-1 genes
46. Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1β. Role of C/EBP factors
47. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene
48. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen
49. Regulation of DNA binding by Rel/NF-κB transcription factors: Structural views
50. The Rel/NF-κB signal transduction pathway: Introduction
51. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist
52. Molecular basis of agonism and antagonism in the oestrogen receptor
53. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
54. Peptide antagonists of the human estrogen receptor
55. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways
56. Expression and hormonal regulation of coactivator and corepressor genes
57. FHL2, a novel tissue-specific co-activator of the androgen receptor
58. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
59. Glucocorticoid osteoporosis-mechanisms and management